Roche launches new test to provide the most comprehensive portfolio for cervical cancer screening

Roche announced today the launch of the fully automated CINtec PLUS cytology test to improve the detection and early intervention of pre-cancerous cervical disease. The CINtec PLUS cytology test helps identify women with high-grade pre-cancerous cervical lesions who need immediate colposcopy.
Source: Roche Media News - Category: Pharmaceuticals Source Type: news